Sensitivity and specificity of transoperative histopathological study compared to definitive histopathological report in patients with thyroid nodule TIRADS 4 and 5

Sensitivity and specificity of transoperative histopathological study compared to definitive histopathological report in patients with thyroid nodule TIRADS 4 and 5

Álvaro J. Montiel-Jarquín 1 , José A. García-Santiago 2, Arturo García-Galicia 3 , Ángel J. Severino-Ovando 4, Carlos A. Cortés-García 5 , Edgar Bautista-Soto 1 , Luis P. Valencia-Montiel 5 , Paola Lima-Hernández 6, Jorge Loría-Castellanos 7 , Nancy R. Bertado-Ramírez 3 , Eduardo Vázquez-Cruz 8, Akihiki M. González-López 8

1 Dirección de Educación e Investigación en Salud, Centro Médico Nacional Gral. de Div. Manuel Ávila Camacho, Hospital de Especialidades de Puebla, Instituto Mexicano del Seguro Social (IMSS) Puebla, México; 2 Dirección de Educación e Investigación en Salud, Unidad Médica de Alta Especialidad. Hospital de Especialidades de Puebla, Centro Médico Nacional Gral. de Div. Manuel Ávila Camacho, Pue., Puebla, México; 3 Unidad Médica de Alta Especialidad Hospital de Especialidades de Puebla, Dirección de Educación e Investigación en Salud, Centro Médico Nacional General de División Manuel Ávila Camacho, Instituto Mexicano del Seguro Social (IMSS). Puebla, México; 4 Dirección de Educación e Investigación en Salud, Unidad Médica de Alta Especialidad, Hospital de Especialidades de Puebla, Centro Médico Nacional Gral. de Div. Manuel Ávila Camacho, Instituto Mexicano del Seguro Social, Puebla, México; 5 Directorate of Education and Research in Health, High Speciality Medical Unit, Specialties Hospital of Puebla,Centro Médico Nacional Gral. de Div. Manuel Ávila Camacho, Instituto Mexicano del Seguro Social, Puebla of Zaragoza, Puebla, Mexico; 6 Centro de Investigación Biomédica de Oriente, Instituto Mexicano del Seguro Social (IMSS), Puebla, México; 7 Coordinación de Proyectos Especiales en Salud, Instituto Mexicano del Seguro Social, Ciudad de México, México; 8 Unidad de Medicina Familiar No. 6, IMSS, Puebla, México

*Correspondence: Álvaro J. Montiel-Jarquín. Email: alvaro.montielj@imss.gob.mx

Date of reception: 15-01-2024

Date of acceptance: 17-01-2024

DOI: 10.24875/AMH.M24000070

Disponible en internet: 27-05-2024

An Med ABC 2024;69(1):1-5

Abstract

Introduction: Thyroid cancer is the most common endocrine malignancy, and survival is 98%. Incidence drops by 2.5% annually as newer criteria are used to diagnose it. Fine needle aspiration biopsy is used in the initial evaluation to obtain a sample. The transoperative histopathological study has an efficacy of > 97% and helps to avoid unnecessary dissections. The diagnostic gold standard is the definitive histopathological study.

Objective: To determine the sensitivity and specificity of the transoperative histopathologic study of the thyroid compared to the definitive histopathologic report in patients with TIRADS 4 and 5.

Method: Observational, comparative, cross-sectional and homodemographic study in patients who underwent hemithyroidectomy surgery and who underwent a transoperative study during the years 2021 and 2022. Descriptive statistics were used, and the results were compared with the definitive histopathological study.

Results: There were 46 patients (5 males and 46 females), mean age 47.35 ± 13.83 years (range: 22-70), sex ratio female > male (8:1). The transoperative study, for TIRADS 4, has a sensitivity of 58.3% and a specificity of 95.4%, with a positive predictive value (PPV) of 87.5% and negative predictive value (NPV) of 80.7%; and for TIRADS 5, a sensitivity of 83.3% and a specificity of 100%, with PPV of 100% and NPV of 85.7%.

Conclusions: Transoperative study in patients with advanced stage thyroid nodule TIRADS 5 has a better sensitivity and specificity than in the other previous stages.

Keywords: Thyroid Cancer. Surgery. Transoperative. Sensitivity. Specificity.

Contents

Introduction

The past three decades have witnessed a constant increase in the incidence of thyroid cancer worldwide1,2. It is diagnosed at an earlier age compared to most other cancers affecting adults2. Women are 3 times more likely to develop thyroid cancer than men2,3. Figures from the European Network of Cancer Registries show estimate incidence rates in women that are approximately 3 times higher versus men4. Although rates vary from one country to another; in Mexico, it is estimated that around 35% of the population will have a thyroid nodule at some point in their lives, and approximately 10% of them will exhibit some form of thyroid cancer5.

Thyroid cancer originates from follicular epithelial cells or parafollicular C cells. Derived from follicular cells, thyroid cancer is categorized into four histological types: papillary thyroid cancer (80-85%), follicular thyroid cancer (10-15%), poorly differentiated thyroid cancer (< 2%), and anaplastic thyroid cancer (< 2%)6,7.

Less invasive alternatives to surgery for treating low-risk thyroid cancer, such as active surveillance and minimally invasive interventions, are being explored8,9. Ultrasound-guided fine-needle aspiration biopsy (FNAB) is the preferred technique for evaluating thyroid nodular disease due to its ease of performance, diagnostic yield, and minimal complications10. The most significant setback of FNAB is the amount of non-diagnostic punctures due to insufficient or hemorrhagic material11,12.

Intraoperative frozen section (IFS), when used correctly, provides important information; however, it is not useful when a definite cytological diagnosis is already available, although its performance varies depending on each particular circumstance13. When the diagnosis has not been established before surgery or in suspected cases of benign lesions where the possibility of malignant neoplasms has not been excluded, the specimen is generally examined with frozen section cuts to determine the need for more extensive surgery intraoperatively14.

When the pre-operative diagnosis is suspicious for papillary carcinoma (Bethesda VI), the IFS has a 100% positive predictive value (PPV) and a 50% negative predictive value (NPV), facilitating the decision to complete total thyroidectomy. In the latter circumstance, the IFS results in an adequate cost-effectiveness ratio; yet, PPV and NPV may vary from one center to the other depending on the prevalence of malignancy15.

Therefore, the utility of available diagnostic tools in the individualized context of each patient should be established, as well as the optimal use of institutional resources, thereby improving diagnostic certainty, guiding clinical judgment, and the treating physician’s decision-making.

The reference diagnostic method is the definitive histopathological examination performed after surgical removal of the thyroid gland16.

The objective of this study was to determine the sensitivity and specificity of IFS compared to definitive histopathological examination in patients with thyroid imaging reporting and data system (TIRADS) 4 and 5 thyroid nodules.

Materials and methods

This study was sensitivity and specificity study of a diagnostic test. Patients > 16 years, of both sexes, diagnosed with thyroid nodules (TIRADS 4 and 5) and undergoing hemithyroidectomy with IFS from June 2021 to June 2022 at a tertiary referral center from Mexico were included in the study.

A review of the surgical schedule of the surgical oncology service was conducted, including patients diagnosed with thyroid nodules who underwent hemithyroidectomy with IFS, and data collection was supplemented with records from the clinical archive and outpatient clinic. Patients whose studies recorded in the health records could not be evaluated or were incomplete were excluded from the study. Patients with indeterminate or inconclusive results were excluded as well.

Data analysis was performed using descriptive statistics. Frequencies and percentages were calculated for non-parametric variables, and measures of central tendency and dispersion (mean, median, mode, minimum, maximum, and standard deviation) for the parametric ones. Sensitivity, specificity, PPV, NPV, and the efficacy of IFS in TIRADS 4 and 5 were determined using the Statistical Package for the Social Sciences 29 statistical processor.

The study was approved by the Local Research and Ethics in Health Research Committee. All participants signed the informed consent letter, and their anonymity was preserved at all times. Data were used solely for scientific purposes.

Results

A total of 46 patients were recruited, with a mean age of 47.35 years ± 13.83 years (range, 22-70) and a female-to-male ratio of 8.2:1. Regarding thyroid function, most (71.7%) were euthyroid, followed by hypothyroidism (26.1%) and hyperthyroidism (2.2%). The right side (69.6%) predominated over the left one (30.4%). According to TIRADS classification, the following frequencies were found: 73.9% were TIRADS 4, and 26.1% were TIRADS 5. Benign histological lineage prevailed over malignant.

In both TIRADS 4 and 5 groups, the IFS versus the definitive histopathological examination have high sensitivity and solid specificity (Fig. 1).

Figure 1. Sensitivity and specificity of intraoperative frozen section in thyroid imaging reporting and data system four and five patients versus the definitive histopathological examination. Sensitivity: 92.3%; specificity: 81.8%; positive predictive value: 66.6%; negative predictive value: 96.4%; and accuracy: 84.7%.

For TIRADS 4, the IFS has a sensitivity rate of 58.3% and a specificity rate of 95.4% (Fig. 2), while for TIRADS 5, the IFS exhibits a sensitivity rate of 83.3% and a specificity rate of 100% (Fig. 3).

Figure 2. Sensitivity and specificity of intraoperative frozen section use in thyroid imaging reporting and data system four patients versus the definitive histopathological examination. Sensitivity: 58.3%; specificity: 95.4%; positive predictive value: 87.5%; negative predictive value: 80.7%; and accuracy: 82.3%.

Figure 3. Sensitivity and specificity of intraoperative frozen section use in thyroid imaging reporting and data system five patients versus the definitive histopathological examination. Sensitivity: 83.3%; specificity: 100%; positive predictive value: 100%; negative predictive value: 85.7%; and accuracy: 91.6%.

Discussion

Thyroid IFS aims to determine which patients present malignant disease intraoperatively, which has an impact on the surgeon’s decision-making regarding performing a more radical surgical technique.

The significance of assessing sensitivity and specificity lies in understanding the utility of IFS compared to the diagnostic standard and distinguishing patients who require more aggressive treatment from those who do not, thus enabling the planning of an optimal approach that limits complications and unnecessary surgeries.

Numerous studies demonstrate very high specificity rates (94%, 75%, and 92%) and considerable sensitivity rates (73%, 94%, and 100%)14. Some more recent studies report similar figures: A sensitivity rate of IFS in benign diagnosis of 94%, a specificity rate of 93%, and efficacy rates of 93.5%17. The results obtained in this study in the overall population are similar to those cited in the global literature.

This study confirms the intrinsic relationship between thyroid cancer and the female versus male sex (8.2:1), which is consistent with the current scientific medical literature available2,3.

In this study, there is a predominance of benign outcomes 3 times greater in TIRADS 4 with respect to positive results for malignancy, while in TIRADS 5, there is a similar ratio of benign and malignant cases. However, this could be due to the fact that, when performing frozen section and multi-cut IFS, some segments may present malignancy; that is, a histological section could not be representative of the entire surgical specimen17,18.

For patients with benign IFS and malignant IFS with tumor-free margins, it was not deem necessary to change the surgical approach by expanding the direction or performing radical thyroidectomy.

There is dominance in the affected right side compared to the left one; yet, this varies depending on the consulted literature.

Euthyroid function is the most prevalent in the studied population. It shows that the nodules are hypocaptant and it is mentioned that this type of nodules has little relation to thyroid cancer5. However, in our population, despite the aforementioned, all had cancer, predominantly benign, nevertheless confirmed by definitive histopathological examination.

The main limitation of this study is the small, single-center studied population. More multicenter studies with a larger population are needed to compare the results obtained in this study.

The combined use of FNAB with IFS is recommended to increase diagnostic sensitivity and specificity17,19. It is advisable to compare the diagnostic sensitivity and specificity of FNAB alone and combined with IFS by stages and compare the outcomes with this study, thus providing a comprehensive overview toward an improved diagnosis in patients with thyroid nodules.

Conclusions

In patients with advanced-stage thyroid nodules (TIRADS 5), IFS has better sensitivity and specificity compared to other previous stages.

Funding

The authors declare that they have not received funding.

Conflicts of interest

The authors declare no conflicts of interest.

Ethical disclosures

Protection of human and animal subjects. The authors declare that no experiments were performed on humans or animals for this study.

Confidentiality of data. The authors declare that no patient data appear in this article. Furthermore, they have acknowledged and followed the recommendations as per the SAGER guidelines depending on the type and nature of the study.

Right to privacy and informed consent. The authors declare that no patient data appear in this article.

Use of artificial intelligence for generating text. The authors declare that they have not used any type of generative artificial intelligence for the writing of this manuscript nor for the creation of images, graphics, tables, or their corresponding captions.

References

1. Filetti S, Durante C, Hartl D, Leboulleux S, Locati LD, Newbold K, et al. Thyroid cancer:ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2019;30:1856-83.

2. Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17-48.

3. Haymart MR. Progress and challenges in thyroid cancer management. Endocr Pract. 2021;27:1260-3.

4. Araque KA, Gubbi S, Klubo-Gwiezdzinska J. Updates on the management of thyroid cancer. Horm Metab Res. 2020;52:562-77.

5. Gallegos-Hernández JF. Aspectos fundamentales del nódulo tiroideo y el cáncer bien diferenciado de tiroides para los médicos general y familiar. Gac Med Mex. 2019;155:619-23.

6. Laha D, Nilubol N, Boufraqech M. New therapies for advanced thyroid cancer. Front Endocrinol (Lausanne). 2020;11:82.

7. Abooshahab R, Gholami M, Sanoie M, Azizi F, Hedayati M. Advances in metabolomics of thyroid cancer diagnosis and metabolic regulation. Endocrine. 2019;65:1-14.

8. Chen DW, Lang BH, McLeod DS, Newbold K, Haymart MR. Thyroid cancer. Lancet. 2023;401:1531-44.

9. Oda H, Miyauchi A, Ito Y, Yoshioka K, Nakayama A, Sasai H, et al. Incidences of unfavorable events in the management of low-risk papillary microcarcinoma of the thyroid by active surveillance versus immediate surgery. Thyroid. 2016;26:150-5.

10. Lee JY, Baek JH, Ha EJ, Sung JY, Shin JH, Kim JH, et al. 2020 imaging guidelines for thyroid nodules and differentiated thyroid cancer:Korean society of thyroid radiology. Korean J Radiol. 2021;22:840-60.

11. Cortázar-García R, Martín-Escalante MD, Robles-Cabeza L, Martínez-Santos C. Utilidad de la biopsia con aguja gruesa ecoguiada en nódulos tiroideos con punción aspirativa con aguja fina no diagnóstica. Radiología. 2022;64:195-205.

12. Rossi ED, Adeniran AJ, Faquin WC. Pitfalls in thyroid cytopathology. Surg Pathol Clin. 2019;12:865-81.

13. Granados-García M, Gallegos-Hernández JF, Quintero-Rodríguez CE, Gurrola-Machuca H, Acuña-Tovar M, Pacheco-Bravo I, et al. Guía de práctica clínica para el diagnóstico y tratamiento del nódulo tiroideo y el carcinoma diferenciado de tiroides. Gac Mex Oncol. 2022;18:53-101.

14. Llamas Padilla LA. Sensibilidad y Especificidad del Estudio Trans-operatorio (ETO) Versus Biopsia por Aspiración con Aguja Fina (BAAF) para el Manejo del Nódulo Tiroideo Realizado en el Hospital General Dr. Miguel Silva. México:Universidad Nacional Autónoma de México;2015. Available from:https://repositorio.unam.mx/contenidos/220284 [Last accessed on 2023 Nov 13].

15. Abu-Ghanem S, Cohen O, Raz Yarkoni T, Fliss DM, Yehuda M. Intraoperative frozen section in “suspicious for papillary thyroid carcinoma”after adoption of the Bethesda system. Otolaryngol Head Neck Surg. 2016;155:779-86.

16. Patel KN, Yip L, Lubitz CC, Grubbs EG, Miller BS, Shen W, et al. The American association of endocrine surgeons guidelines for the definitive surgical management of thyroid disease in adults. Ann Surg. 2020;271:e21-93.

17. Ramírez-Cerda CA, Guzmán-Navarro L, Vidal-González P. Utilidad de la biopsia transoperatoria en el manejo quirúrgico del nódulo tiroideo. Cir Cir. 2009;77:21-7.

18. Sclabas GM, Staerkel GA, Shapiro SE, Fornage BD, Sherman SI, Vassillopoulou-Sellin R, et al. Fine-needle aspiration of the thyroid and correlation with histopathology in a contemporary series of 240 patients. Am J Surg. 2003;186:702-10.

19. Chow TL, Venu V, Kwok SP. Use of fine-needle aspiration cytology and frozen section examination in diagnosis of thyroid nodules. Aust N Z J Surg. 1999;69:131-3.